| Authors: |
Lee JSF; Drugs for Neglected Diseases initiative (DNDi), 15 Chemin Louis Dunant, 1202, Geneva, Switzerland. jlee@dndi.org., Sagaon Teyssier L; INSERM, UMR912 'Economics and Social Sciences Applied to Health & Analysis of Medical Information' (SESSTIM), 13006, Marseille, France.; Aix Marseille University, UMR_S912, IRD, 13006, Marseille, France.; ORS PACA, Southeastern Health Regional Observatory, 13006, Marseille, France., Dongmo Nguimfack B; HIV Department, World Health Organization, Geneva, Switzerland., Collins IJ; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Lallemant M; Drugs for Neglected Diseases initiative (DNDi), 15 Chemin Louis Dunant, 1202, Geneva, Switzerland., Perriens J; HIV Department, World Health Organization, Geneva, Switzerland., Moatti JP; INSERM, UMR912 'Economics and Social Sciences Applied to Health & Analysis of Medical Information' (SESSTIM), 13006, Marseille, France.; Aix Marseille University, UMR_S912, IRD, 13006, Marseille, France.; ORS PACA, Southeastern Health Regional Observatory, 13006, Marseille, France. |